Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Senators press Moderna CEO on COVID-19 vaccine price hike

Por: WPLG Local 10 Politics March 23, 2023

thumbnail

Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Stephane Bancel told the Senate Committee on Health, Education, Labor and Pensions that the drugmaker will charge a list price of around $130 per dose for the vaccine in the U.S.That price is expected to go into effect later this... + full article



Similar News

Senators press Moderna CEO on COVID-19 vaccine price hike

ABC News USA Business March 23, 2023

thumbnailModerna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Stephane Bancel told the Senate Committee on Health,... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate


Senators press Moderna CEO on COVID-19 vaccine price hike

Portland Press Herald USA Health March 23, 2023

thumbnailModerna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Moderna CEO Stephane Bancel testifies during the Senate HELP... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate


Senators press Moderna CEO on COVID-19 vaccine price hike

Orlando Sentinel USA Nation March 23, 2023

thumbnailModerna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Stephane Bancel told the Senate Committee on Health,... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate


Sliding vaccine sales, new costs, squeeze Moderna 4Q profit

Associated Press USA Health February 23, 2023

Moderna’s fourth-quarter profit tumbled 70% as COVID-19 vaccine sales fell and the drugmaker caught up on a royalty payment.Heavy research and development costs also weighed on Moderna as the vaccine developer looks to strengthen an income statement currently dominated by its... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate


Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history

CNBC USA Health December 06, 2022

thumbnailVials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop?

Forbes USA Business November 29, 2022

thumbnailGetty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Moderna sues Pfizer over patents behind COVID-19 vaccine

The Advocate USA Crime October 10, 2022

thumbnailvaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más

Moderna is suing Pfizer over its coronavirus vaccine | The Verge

Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times



About iurex | Privacy Policy | Disclaimer |